9552 — Quants Research Institute Holdings Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Quants Research Institute Holdings, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | R2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,177 | 3,981 | 7,430 | 10,202 | 5,040 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 53.9 | 9.92 | 143 | 700 | 981 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,245 | 4,034 | 7,654 | 11,021 | 6,258 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 24.6 | 27.8 | 67.8 | 618 | 953 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,354 | 4,229 | 8,327 | 12,524 | 8,123 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 440 | 1,205 | 2,673 | 3,308 | 2,673 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 576 | 1,299 | 2,728 | 3,611 | 3,019 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 778 | 2,930 | 5,600 | 8,913 | 5,105 |
| Total Liabilities & Shareholders' Equity | 1,354 | 4,229 | 8,327 | 12,524 | 8,123 |
| Total Common Shares Outstanding |